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Résumé 
 
Les biofilms sont des communautés structurées de micro-organismes enrobées dans 
une matrice extracellulaire. Les biofilms sont impliqués dans la persistance de plusieurs 
maladies infectieuses et la matrice extracellulaire du biofilm protège les bactéries contre les 
cellules du système immunitaire de l'hôte, les antibiotiques et les désinfectants. Récemment 
notre laboratoire a démontré que le zinc inhibe la formation de biofilm chez Actinobacillus 
pleuropneumoniae, une bactérie pathogène du porc.  
 
Le but de cette étude est d'évaluer l'effet du zinc sur la croissance et la formation du 
biofilm chez différentes bactéries pathogènes du porc, telles que Bordetella bronchiseptica, 
Escherichia coli, Haemophilus parasuis, Salmonella, Staphylococcus aureus et 
Streptococcus suis. Les bactéries ont été cultivées dans des plaques de 96 puits sous 
condition optimale de formation de biofilm et  les biofilms ont été colorés au cristal violet. 
La présence du biofilm a été confirmée par microscopie confocale à balayage laser à l’aide 
du marqueur fluorescent FilmTracerTM FM ® 1-43. À des concentrations micromolaires, le 
zinc inhibe faiblement la croissance bactérienne et bloque d'une manière dose-dépendante 
la formation de biofilm d’A. pleuropneumoniae, Salmonella Typhimurium et  H. parasuis. 
De plus, la formation de biofilm de E. coli, S. aureus et S. suis a été faiblement inhibée par 
le zinc. Nos résultats indiquent que le zinc a un effet inhibiteur sur la formation de biofilm 
de la plupart des pathogènes bactériens d'origine porcine. Cependant, le mécanisme sous-
jacent de l'activité anti-biofilm du zinc reste à être caractérisé. 
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iii 
 
 
Abstract 
 
Biofilms are structured communities of microorganisms enclosed in a self-produced 
extracellular matrix. Biofilms are responsible for the persistence of most infectious 
diseases, because the biofilm matrix acts as a form of protection for the bacteria against the 
host immune system, antibiotic and disinfectants. Recent work in our laboratory 
demonstrated that zinc could inhibit biofilm formation of Actinobacillus 
pleuropneumoniae, a swine pathogen.  
 
The aim of this study was to evaluate the effect of zinc on growth and biofilm 
formation of other bacterial swine pathogens, such as Bordetella bronchiseptica, 
Escherichia coli, Haemophilus parasuis, Salmonella, Staphylococcus aureus, and 
Streptococcus suis. Bacteria were grown on 96-well plates under optimal biofilm forming 
conditions and the biofilms were stained with crystal violet. The presence of biofilms was 
confirmed by confocal laser scanning microscopy with FilmTracerTM FM® 1-43. At 
micromolar concentrations, zinc weakly inhibited bacterial growth and effectively blocked 
biofilm-formation by A. pleuropneumoniae, Salmonella Typhimurium, and H. parasuis in a 
dose-dependent manner. Additionally, biofilm formation of E. coli, S. aureus and S. suis 
was slightly inhibited by zinc. Our results indicate that zinc has an inhibitory effect on 
biofilm formation of most bacteria of porcine origin. However, the mechanism behind the 
antibiofilm activity of zinc has yet to be characterized. 
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Microorganisms exist in two forms in nature, a planktonic form and a sessile form. 
Free-swimming cells in planktonic form are related to proliferation and the sessile form is 
called biofilm, which helps a bacterial population to persist. Biofilm are not only involved 
in human diseases but also in animal diseases. Biofilm bacteria can grow on living or 
nonliving surfaces. Biofilms are difficult to eradicate once they are established. Five steps 
are involved in biofilm formation: initial attachment, irreversible attachment, early 
development of biofilm architecture, maturation of biofilm, and dispersion. Two 
fundamental bacterial small-molecule signalling pathways, extracellular quorum-sensing 
(QS) and intracellular cyclic dinucleotide signalling (c-di-GMP) are associated with biofilm 
formation. An interaction seems to exist between QS and c-di-GMP. QS might regulate 
biofilm formation through the regulation of c-di-GMP systems.  
 
Biofilm matrix protects embedded bacteria from host immune system and harmful 
environmental conditions such as antimicrobial agents. Several properties of the biofilm are 
attributed to this resistance, including limited penetration of the compound, limited growth 
of the bacteria, the formation of persister cells (a subpopulation of bacteria differentiated 
into a dormant state), and antibiotic-induced resistance phenotypes. Biofilm matrix is 
composed of different types of biopolymers, called extracellular polymer substance (EPS). 
The main components of biofilm matrix are extracellular polysaccharides, proteins and 
nucleic acids. These molecules contribute to the structures and functions of biofilms.  
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Various veterinary infections associated with biofilm are difficult to treat with   
antibiotics or disinfectants. Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, 
Escherichia coli, Haemophilus parasuis, Salmonella spp, Staphylococcus aureus, and 
Streptococcus suis are important pathogenic bacteria involved in swine infectious diseases. 
The aim of this study was to evaluate the effect of zinc on growth and biofilm formation of 
these bacterial swine pathogens. 
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1. Definition of the biofilm 
 
In virtually all ecosystems, microorganisms can grow in an enclosed community 
known as biofilms. Generally, biofilm can be defined as a structured community of 
microorganisms enclosed in self-produced extracellular polymer substances (EPS) 
(Costerton et al. 1999; O’Toole et al. 2000; Donan 2002; Branda et al. 2005; Hall-Stoodley 
and Stoodley 2009). Microorganisms exist in two states, a planktonic form (free-
swimming) and sessile form. Bacteria in the planktonic form are involved in proliferation 
and those in the sessile form allow a population to persist. Biofilm development is a highly 
complex process and involves the switch from the planktonic form to a sessile life-style. 
Biofilms are seen as complex differentiated communities (Stoodley et al. 2002). It is widely 
accepted that the biofilm life-style can protect microorganisms against the host immune 
system and harmful environmental conditions, and this protection enables microorganism 
to survive and thrive (Anderson and O’Toole 2008).  
 
Anton van Leeuwenhoek is credited with the discovery of microbial biofilm. In 
1683, he scraped the plaque from his teeth, and first observed microorganisms on tooth 
surfaces using his simple microscopes (Donan 2002). In the 1970s, sessile bacteria were 
first described as biofilms, and were considered to constitute a major component of the 
bacterial biomass in the environments. In the 1980s and 1990s, researchers began to 
appreciate that attached bacteria were organized in elaborate ways (Costerton et al. 1999). 
For example, in 1991, Lawrence took the first confocal laser scanning microscopy (CLSM)  
images of living biofilms, and these images showed the sessile bacteria grown in matrix-
covered microcolonies (Lawrence et al. 1991). Although biofilms have been well known 
for several years, the importance of biofilm in animal diseases has been overlooked until 
recently (Jacques et al. 2010).  
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2. The importance of biofilm 
 
A wide range of human infections are associated with bacterial biofilms, including 
otitis media, osteomyelitis, endocarditis and cystic fibrosis pneumonia (Costerton et al. 
1999). Biofilms are also involved in various diseases of veterinary importance, such as 
pneumonia, liver abscesses, enteritis, wound infections and mastitis infections (Clutterbuck 
et al. 2007; Jacques et al. 2010). 
2.1 Biofilm chronic infections 
 
Although bacterial attachment is a feature of all infections, biofilm infections are 
differentiated by the aggregation of microcolonies attached on a surface. Biofilms lead to 
several clinical problems, including inflammation, antibiotic resistance, recurrence or 
persistence and metastasis or the spread of infectious emboli. It is widely recognized that 
biofilms cause or exacerbate a large number of chronic infections (Hall-Stoodley et al. 
2004; Hall-Stoodley and Stoodley 2009). Biofilm infection is difficult to diagnose because 
accurate predictor have yet to be identified. Parsek and Singh (2003) made an outline of 
specific criteria for diagnosis of biofilm infections. For example, infecting bacteria should 
be adherent or attached to the substratum; bacterial clusters or microcolonies encased in an 
extracellular matrix should be directly visualized; infections should be localized to a 
particular anatomical site; bacteria should show increased resistance to antibiotics 
compared to their planktonic counterparts. 
 
Biofilm infections are mainly located at epithelial sites. The infections are recurrent 
or long-lasting in spite of host immune response and antibiotic therapy. At the beginning of 
bacterial infections, antibiotics, antibodies and phagocytes can clear the free bacteria. Once 
attached to the surface, the sessile bacterial cells produce the biofilm and these cells 
become resistant to antibodies, phagocytes as well as antibiotics. Phagocytes are attracted 
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to the biofilms. Phagocytic enzymes are released to surrounding tissues which cause 
damages to the tissues. Planktonic bacteria are also released which causes dissemination of 
the infection to a different site (Figure 1).  
 
 
Figure 1: The biofilm formation and its resistance to immune system of host. Antigens 
released by sessile bacteria stimulate an antibody  response which neutralizes the bacteria, 
but bacteria within the biofilm are not susceptible to those antibodies. (Costerton et al. 
1999) 
2.2 Biofilms in animal and human diseases 
 
Using the Calgary Biofilm Device (CBD), biofilms were demonstrated to be 
associated with veterinary infectious diseases of cattle, sheep, pigs, chicken, and turkeys 
(Olson et al. 2002). Additionally, biofilm formation is also related to numerous human 
chronic infections such as periodontitis, device-related infections, CF pneumonia, chronic 
urinary tract infection, recurrent tonsillitis, chronic rhinosinusitis, chronic otitis media and 
chronic wound infections. Chronic wounds include diabetic foot ulcers, pressure ulcers as 
well as venous leg ulcers. (Hall-Stoodley and Stoodley 2009). In veterinary diseases, 
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infected wounds are a typical biofilms-associated infection and are regarded as a key 
problem in the hospitalized animal (Clutterbuck et al. 2007). Bacterial biofilm are more 
prevalent in chronic wounds than acute wounds. Biofilm-related wound diseases are 
typically persistent infections that develop slowly, are rarely resolved by immune defences, 
and respond poorly to antimicrobial therapy (James et al. 2008).  
3. Biofilm formation 
 
Microorganisms can grow a biofilm on both biotic and abiotic surfaces including 
those found in soil and aquatic systems, or indwelling medical devices. Once biofilms are 
attached, it becomes difficult to eradicate them. Biofilm formation involves the following 
five steps: reversible attachment, irreversible attachment, growth, maturation, and 
detachment and dispersion (Figure 2).   
 
 
Figure 2: Diagram of the five steps involved in biofilm development: 1) initial attachment, 
2) irreversible attachment, 3) early development of biofilm architecture, 4) maturation of 
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biofilm architecture and 5) dispersion. Images below the cycle steps show the microscopic 
appearance of the biofilm at each step. (Stoodley et al. 2002) 
3.1 Reversible and irreversible attachment 
 
Specific environmental cues are needed to stimulate biofilm development, and 
include temperature, pH,  nutrient availability. These cues vary between species (O’Toole 
et al. 2000). For the first step to be initiated, bacteria need to be very close to the surface to 
allow for the initial attachment. This initial reversible attachment is associated with non-
specific interactions such as electrostatic, van der Waals, and hydrophobic interactions. 
Surface charge and hydrophobic interactions are the factors responsible for the adherence 
of the cell to the surface. During this initial contact, bacteria can be easily removed by shear 
forces such as rinsing. The following step is the transition from reversible attachment to 
irreversible attachment. In this attachment process, bacteria lock onto the surface by the 
production of extracellular polysaccharides and/or specific adhesins, such as pili or 
fimbriae that may form a complex with the surface. Much stronger physical or chemical 
forces are required to remove the bacteria from the surface after this step (Palmer et al. 
2007).  
3.2 Biofilm growth and maturation 
 
Once bacteria are strongly attached to the surfaces, the bacteria begin to multiply 
and develop the extracellular polymer substances (EPS) to help maintain the microcolony 
and biofilm structure (Stoodley et al. 2002). The biofilm matrix keeps the bacterial cells 
together and firmly attaches the bacterial mass to the surface. The mature biofilm is 
characterized by the presence of three-dimensional structures containing a large number of 
tightly organized cells. In some cases, the structure of a biofilm will look like a mushroom 
(Hall-Stoodley et al. 2004). The three dimensional organization of the biofilm is important 
for liquid flow to permit the distribution of nutrients and the disposal of wastes 
(McLandsborough et al. 2006). EPS help bacteria to enhance nutrient capture and to resist 
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environmental stress and antimicrobial agents (Mah and O’Toole 2001). Since pH, oxygen 
concentration, nutrient availability and cell density within biofilms vary, heterogeneity in 
metabolic activity and replication exists among cells located in different parts of the biofilm 
(Kaplan 2010). 
3.3 Biofilm dispersal  
 
Biofilm detachment and dispersal is the final stage of the biofilm development, this 
step is characterized by the detachment of cells from the biofilm and their dispersal into the 
environment. Biofim dispersal is the crucial step in the biofilm life cycle due to its 
contribution to the dispersal and survival of bacteria, and disease transmission. Three 
distinct phases are involved in biofilm dispersal: detachment of cells from the biofilm, 
translocation of the cells to a new surface and reattachment of the cells to a new surface 
(Kaplan 2010). Extracellular enzymes produced by bacteria can degrade matrix 
components and it is a well-known mechanism of dispersal. For example, dispersin B 
(DspB), a glycoside hydrolase produced by Aggregatibacter (Actinobacillus) 
actinomycetemcomitans and A. pleuropneumoniae, degrades poly-N-acetylglucosamine 
(PGA), an important component of some biofilm matrices (Kaplan et al. 2004; Kerrigan  et 
al. 2008). In addition, several extracellular proteases have been reported as crucial player in 
biofilm detachment. For example, the increasing production of extracellular proteases 
accelerates the detachment of biofilm of S. aureus and this indicates that biofilm 
detachment requires extracellular protease (Boles and Horswill 2008). Degradation of 
biofilm matrix extracellular DNA (eDNA) is also associated with biofilm detachment. The 
staphylococcal thermonuclease degrades eDNA and plays a significant role in biofilm 
dispersal (Mann et al. 2009).  
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3.4 Extracellular and intracellular signalling in biofilm 
formation 
 
Small molecules are used by bacteria as extracellular and intracellular signals. This 
kind of signalling information is integrated by bacteria and allows bacteria to respond to 
various changes in the environment. Two fundamental signalling pathways, the 
extracellular quorum-sensing signalling and the intracellular cyclic dinucleotide signalling, 
are involved in the regulation of biofilm formation (Camilli and Bassler 2006). 
3.4.1 Quorum sensing 
 
Specific extracellular signals regulate activation of the metabolic pathways that 
induce biofilm formation. These signals are produced by the bacterial community, and are 
called autoinducers, whose concentration is related to the density of the cell population. 
Autoinducers lead to multicellular responses in the bacterial population by triggering signal 
transduction cascades. This mechanism of cell-cell communication in bacteria is termed 
quorum sensing (Figure 3). QS associates with the production, release and detection of 
chemical signalling molecules, and then allows microbial cells to regulate gene expression 
according to cell-density (Camilli and Bassler 2006; Vu et al. 2009; Lopez et al. 2010;).  
 
In a QS system, individual cells release small QS signalling molecules and cells 
respond to the signals from the surrounding environment in a coordinated manner. Among 
QS systems, several major types have been identified. Two types of small molecule 
autoinducers, acyl homoserine lactones (called as HSL or AHL) signals and autoinducer 
peptides (AIPs) are predominately used in Gram-negative and Gram-positive bacteria, 
respectively (Figure 3).  
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3.4.2 c-di-GMP 
 
The second messenger cyclic diguanylic acid (c-di-GMP) is widely known as a 
central regulator for the formation and maintenance of biofilms in a large number of 
organisms. High c-di-GMP levels can stimulate various biofilm-associated functions (Jenal 
and Malone 2006; Romling and Amikam 2006; Cotter and Stibitz 2007; Hengge 2009).  
 
The c-di-GMP is synthesized by diguanylate cyclase (DGC) and degraded by 
phosphodiesterase A (PDEA). DGCs have similar sequences, and are called GGDEF 
proteins after the conserved residues in their active site. PDEAs are members of the EAL 
(conserved protein domain with PDEA activity) domain family, and their name is also 
based on the conserved residues of their active site. Other cellular functions are also 
regulated by c-di-GMP (Figure 4). In the c-di-GMP regulatory system, GGDEF and EAL 
domain proteins control intracellular c-di-GMP levels, thus regulate the transition between 
biofilm and planktonic lifestyles (Cotter and Stibitz 2007).  
3.4.3 Relation between quorum-sensing and c-di-GMP systems 
 
Bacteria use both the QS via AI molecules and c-di-GMP signalling to control the 
formation and dispersion of biofilm. c-di-GMP acts as an intracellular secondary messenger 
that stimulates biofilm formation. QS influences the transcription of genes involved in the 
production of c-di-GMP, GGDEF and/or EAL domains. Therefore, QS might have the 
ability to regulate biofilm formation through modulation of intracellular c-di-GMP levels. 
There seems to be an interaction between QS and c-di-GMP during biofilm formation of 
bacteria (Waters et al. 2008). 
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4. Biofilm resistances 
 
Bacteria grown in biofilms are protected from antimicrobial agents and the host 
immune system that normally eradicate planktonic cells. This type of resistance is unique to 
biofilm-associated bacteria and various resistance mechanisms have been proposed 
(Costerton et al. 1999; Donlan and Costerton 2002; del Pozo and Patel 2007; Lewis 2010). 
 
A 
 
B 
 
 
Figure 3: Different quorum sensing systems in Gram-negative bacteria and Gram-positive 
bacteria. Quorum sensing systems in Gram-negative bacteria (A). Acyl-homoserine lactone 
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(HSL or AHL) signals (blue circles) are produced by the LuxL enzyme homologues that 
bind to LuxR homologues to activate expression of target genes. (Aa) At low cell densities, 
concentration of the signal is low inside and outside the cell, and results in minimal 
activation of LuxR. (Ab) At high cell densities, acyl-HSL binds and activates LuxR which 
leads to the regulation of the expression of target genes. Quorum sensing in Gram-positive 
bacteria (B). AIPs are produced as precursor peptides and exported outsite the cell. (Ba) At 
low cell densities, concentration of the AIP signal is low outside the cell and there is no 
activation of the response regulator (RR). (Bb) At high cell densities, concentration of the 
AIP is high which results in the AIP binding to a histidine kinase receptor. Activation of the 
histidine kinases leads to phosphorylation of the RR and regulation of the expression of 
genes targeted by the RR. (Jayaraman and Wood 2008). 
 
 
 
 
Figure 4: Schematic of the synthesis and hydrolysis of c-di-GMP. Stippled lines show the 
allosteric control of DGC and PDEactivities. (Jenal and Malone 2006) 
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4.1 Biofilm resistance to host immune system  
 
Bacteria embedded in the biofilm are hard to be destroyed by the first line of host 
defences, phagocytic cells. Several factors account for the failure of the host’s immune 
system to kill biofilms (Clutterbuck et al. 2007). The mechanisms of biofilm resistance to 
leukocyte killing and clearance may include several factors, such as limited penetration of 
leukocytes into the biofilm matrix, inhibitory effect of biofilm matrix on leukocyte-specific 
processes, decreased ability to phagocytize biofilm bacteria by leukocytes, increased 
resistance to leukocytes by a global response regulation in biofilm, genetic switch inducing 
the increase production of components associated in immune evasion (Leid et al. 2005). For 
example, polysaccharide intercellular adhesin (PIA) produced by S. aureus, is essential for 
immune evasion. PIA is involved in biofilm formation and protects bacterial cells against 
innate host defence. A PIA-mutant strain was more susceptible to major antibacterial 
peptides (Vuong et al. 2004a, b; Foster 2005). Staphylococcus epidermidis biofilm protect 
S. epidermidis from phagocytic uptake and inhibit macrophage activation (Schommer et al. 
2011). Furthermore, S. aureus biofilms attenuate the production of inflammatory mediator 
and inhibit the invasion of macrophages into the biofilm. S. aureus biofilms do not activate 
the classical TLR recognition pathways, which likely limit the ability of tissue 
macrophages to invade biofilms (Thurlow et al. 2011).  
4.2 Antimicrobial resistance of biofilm 
 
Bacteria in biofilm are 10 to 1000 fold more resistant to various antimicrobial 
agents than their planktonic counterpart (Mah and O´Toole 2001). Antibiotic therapy has 
been commonly applied to prevent bacterial colonization and to eradicate existing 
infections. However, biofilm-associated infection results in antibiotic resistance which 
leads to ineffective antibiotic treatment of these infections (Stewart and Costerton 2001; 
Davies 2003; Clutterbuck et al. 2007). Growth as a biofilm results in an altered genetic 
regulatory patterns. These changes protect bacteria from antibiotic killing. Several factors 
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associated with the innate properties of biofilm affect antibiotic resistance. For example, the 
biofilm matrix acts as a diffusion barrier and limits antibiotic diffusion through the biofilm, 
and prevents antibiotic from reaching their targets. In biofilms, limited penetration result in 
the cells death in the outer layer of bacteria and low level of antimicrobial exposure to 
deeper regions of the biofilm (Szomolay et al. 2005). Some antimicrobial agents, such as 
tobramycin and ciprofloxacin can penetrate biofilms to kill the bacteria (Walters et al. 
2003).  
 
The reduced levels of oxygen or nutrient result in the slow growth of bacteria 
embedded in the biofilm. Metabolic activity is stratified in biofilms. Higher activity present 
at the surface of the biofilm is observed whereas low or no activity is recorded in the inner 
part of biofilm. The reduced growth rate results in resistance of biofilms to some 
antimicrobial agents (Costerton et al. 1999; Mah and O’Toole 2001; Hoiby et al. 2010). 
Tobramycin and ciprofloxacin are only able to kill metabolically active bacterial located in 
zones with high oxygen concentration. 
 
Additionally, a small subpopulation of bacteria within biofilms is thought to 
differentiate into persister cells. Persister cells are not metabolically active and will not be 
killed by antibiotics. In chronic infections, the majority of cells are killed by antibiotics, 
and the immune system eliminates the regular cells and persister cells from the 
bloodstream. The remaining live cells persist in biofilm. These persisters seem to be the 
main factor responsible for the persistance of chronic infections during antimicrobial 
therapy (Lewis 2010) 
 
Within biofilms, some resistance genes are specifically regulated leading to 
decreased growth and altered metabolism, and persister cells (Donan 2002; Anderson and 
O’Toole 2008). The resistant phenotype of biofilm cells might be induced by nutrient 
limitation, low oxygen stress response, high cell density. Some genes involved in the 
increased-resistance phenotype were related to biofilm phenotype (Mah et al. 2003). Many 
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antibiotics do not kill the cells at subinhibitory concentrations, but induce gene expression 
associated with stress response (Yim et al. 2007).  
 
 
 
 
 
 
Figure 5: Mechanism of antibiotic resistance by biofilms. The single biofilm macrocolony 
is composed of bacteria (ovals) surrounded by an extracellular matrix (multicolored 
background). Small dark dots represent the antibiotic molecules to which the biofilm has 
been exposed. Limited antibiotic diffusion through the matrix might protect bacteria buried 
deep within the biofilm from antibiotic action. Oxygen and nutrient concentrations also 
decrease in the deeper parts of the biofilms and this is represented by a color gradient form 
red (aerobic and high nutrient concentrations) to green (anaerobic and low nutrient 
concentrations). The gradients slow the growth of bacteria in the deepest zone of the 
biofilm (tan), and thus facilitate survival of bacteria in the presence of antibiotic that 
typically kill only fast growing microorganisms (magenta). The red to green gradient also 
represents other possible variations within the heterogeneous biofilm, such as pH. Persister 
cells are considered non-growing or slow-growing, and are represented by blue ovals 
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scattered throughout the biofilm. Finally, the green ovals denote biofilm bacteria 
expressing specific biofilm activated resistance genes. Differential expression of these 
genes (different shade of green) in response to environmental gradients in the community 
might influence the antibiotic resistance state of individual bacteria within the biofilm. 
(Anderson and O’Toole 2008) 
5. The composition of biofilms 
 
In most biofilms, the matrix accounts for over 90% of the dry mass and the 
microorganisms account for less than 10%. The matrix consists of different types of 
biopolymers, known as extracellular polymeric substances (EPS). The EPS is like the 
“house of the biofilm cells”, if the biofilm is “a city of microbes” (Watnick and Kolter 
2000; Flemming et al. 2007). In all biofilms, the EPS is a complex and extremely important 
component, which provides the architectural structure and mechanical stability to the 
population (Allison 2003). Figure 6 shows the mushroom-like structure of biofilms. Sessile 
cells constitute a small part of the matrix-enclosed community. Water channels are well 
organized for conducting water in convective flow and delivering nutrients to other parts of 
the community. EPS formed an additional barrier between the bacterium and it surrounding 
environment (Bazaka et al. 2011). 
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Figure 6: Diagram of  biofilm structure. The arrows indicate the flow of water and nutrients 
within water channels at the base of the biofilm  reaching most parts of the community. 
(Costerton, 2003) 
 
Much of the biofilm matrix is water, and it accounts for up to 97% of the wet mass. 
Water can be bound within the capsules of microbial cells or can exist as a solvent whose 
physical properties are determined by the solutes dissolved in it (Sutherland 2001; Allison 
2003). Water hydrates the EPS matrix which reduces the rate of drying and thus buffers the 
biofilm cells against fluctuation in water potential (Flemming and Wingender 2010). The 
EPS forms a three-dimensional network of cross-linking polymeric strands than can retain 
water more than 15 times its weight. EPS can protect the biofilm-embeded bacteria in 
unsaturated soils resulting in hydraulic decoupling during rapid wetting or drying events 
(Or et al. 2007). 
 
Polysaccharides were thought to be the main component in EPS and therefore the 
abbreviation ‘‘EPS’’ was mostly used to describe the extracellular polysaccharides. Recent 
studies have shown that the biofilm matrix is composed of several components. Therefore, 
the term EPS refers to  polysaccharides, proteins, nucleic acids and other biopolymers 
situated outside the cell (Eboigbodin and Biggs 2008; Vu et al. 2009). These components 
are secreted and organized into a structure by biofilm cells such that it encases and 
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immobilizes the microorganisms as aggregate and help the retention of water (Flemming et 
al. 2007; Flemming and Wingender 2010). The chemical structure of EPS secreted by the 
biofilm cells into the environment varies among species. EPS compounds may also differ 
within bacterial species. The variability of EPS among microorganism can be applied to 
identify and classify cells (Czaczyk and Myszka 2007). 
5.1 Extracellular polysaccharides 
 
Bacteria produce extracellular polysaccharides that significantly impact bacterial 
virulence. Extracellular polysaccharides can be classified as capsular polysaccharides or 
exopolysaccharides. When bacteria are grown in growth medium, and then centrifuged, 
extracellular polysaccharides that remain cell-associated are considered to be part of the 
capsule, while those remaining in the supernatant are referred to as the exopolysaccharides. 
This distinction is not easy to make since many extracellular polysaccharides produced in 
biofilms are insoluble and hard to separate from the cells (Branda et al. 2005).  
 
Bacterial extracellular polysaccharides are key components and features of the 
extracellular matrix of biofilms. Extracellular polysaccharides contribute various functions 
in biofilm matrix such as adherence to surfaces and other cells, structural support, and 
resistance to host and environmental stress (Sutherland 2001). The nature of biofilm 
extracellular polysaccharide depends on the variety of growth conditions, medium, and 
substrates (Lopez et al. 2010). Some extracellular polysaccharides are 
homopolysaccharides such as cellulose. Other extracellular polysaccharides are 
heteropolysaccharides with neutral and charged sugar residues. Some extracellular 
polysaccharides are polyanionic due to the presence of uronic acids, such as alginate, 
xanthan and colonic acid. Meanwhile, other extracellular polysaccharides belong to 
polycationic ones, such as PIA, which is composed of a linear chain of N-acetyl-D-
glucosamine (GlcNAc) residues in β (1, 6) linkage (Flemming and Wingender 2010). This 
polymer is referred as poly-N-acetylglucosamine, called PGA in A. pleuropneumoniae or 
PIA in Staphylococcus spp (Kaplan et al. 2004).  
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One of the best characterized matrix polysaccharide is PGA/PIA which functions as 
a biofilm extracellular polysaccharide matrix in phylogenetically diverse bacterial species. 
PGA is associated with intercellular adhesion and attachment of cells to the surfaces. PIA 
synthesis is involved in biofilm formation by various bacteria (Rohde et al. 2010). PIA is 
the major component for intercellular adhesion, and can be synthesized by enzymes 
encoded by the icaADBC operon. PIA is also found in S. epidermidis, S. aureus, S. caprae, 
S. lugdunensis and S. haemolyticus.  
 
Aggregatibacter (Actinobacillus) actinomycetemcomitans and A. pleuropneumoniae 
have the ability to produce an enzyme which can hydrolyze PGA/PIA, called dispersin B 
(DspB), to release their biofilms. DspB appears to be a potential antibiofilm drug (Kaplan 
et al. 2003; Kerrigan et al. 2008). DspB, although not produced by staphylococci, still can 
degrade PGA/PIA, and break staphylococcal biofilms (Kaplan et al. 2004; Otto 2008).  
5.2 Extracellular DNA 
 
Extracellular DNA (eDNA) play a key role in the composition and formation of 
biofilms (Whitchurch et al. 2002). In Bordetella biofilm, eDNA is a crucial structural 
component of the biofilm matrix formed in vitro and in vivo (Conover et al. 2011). DNA 
release and transformation is referred as one part of a biofilm-related life cycle and eDNA 
can be considered as a source of genes for horizontal gene transfer. Meanwhile, the released 
DNA keeps the stability of the biofilm structure (Molin and Tolker-Nielsen 2003). Initial 
adhesion to surfaces and aggregation of bacteria are vital steps in the process of biofilm 
formation. The presence of eDNA on bacterial cell surfaces enhances adhesion and surface 
aggregation (Das et al. 2010). eDNA plays an important role in the initial phase of biofilm 
development by S. epidermidis on polystyrene or glass surfaces under static or 
hydrodynamic conditions (Qin et al. 2007). 
 
The origin of eDNA appears to be different among species (Flemming and 
Wingender 2010). Different bacteria within biofilm can release DNA at different levels in 
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the biofilm matrix (Cheng et al. 2011). eDNA is considered to be the result of cell lysis 
(Molin and Tolker-Nielsen 2003). On the other hand, Helicobacter pylori biofilm is 
composed of eDNA that largely did not originate from the bacteria but from another source 
(Grande et al. 2011).  
5.3 Extracellular Proteins 
 
The biofilm matrix includes a large amount of proteins. Some extracellular proteins 
in biofilm matrix are involved in biofilm formation. For example, many proteinaceous 
cellular appendages, such as pili, flagella and fimbriae, which are major structural 
components used to connect cells to each other or to different surfaces (Lopez et al. 2010).  
 
Other extracellular proteins, such as cell surface-associated and extracellular 
carbohydrate-binding proteins (lectins), are related to the formation and stabilization of the 
polysaccharide matrix and act as a connection between the bacterial surface and 
extracellular EPS (Flemming and Wingender 2010).   
6. Biofilm formation of selected veterinary pathogens 
 
Various veterinary organisms have the ability to form the biofilms (Olson et al. 
2002). Biofilm formation in animal pathogens has been recently reviewed (Jacques et al. 
2010).  
6.1 Actinobacillus pleuropneumoniae 
 
A. pleuropneumoniae is a Gram-negative bacterium that belongs to the 
Pasteurellaceae family, and is the etiological agent of porcine contagious 
pleuropneumonia, a severe respiratory disease of swine. A. pleuropneumoniae binds cells of 
the lower respiratory tract in a process involving different adhesins and probably biofilm 
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formation (Izano et al. 2007; Bossé et al. 2010; Chiers et al. 2010). The pgaBC genes were 
upregulated when A. pleuropneumoniae adhere to SJPL cells, showing that the biofilm 
formation may be responsible for the colonization and persistence of A. pleuropneumoniae 
in vivo (Auger et al. 2009). Biofilm formation might be part of the response to envelop 
damage caused by the host immune system, resulting in the persistence of A. 
pleuropneumoniae within tonsils or sequestered lung lesions (Bossé et al. 2010). 
 
In previous studies, A. pleuropneumoniae has been reported to have the ability to 
form biofilms under certain growth conditions (Kaplan and Mulks 2005; Labrie et al. 
2010). PGA, encoded by pgaABCD, is a polysaccharide of the biofilm matrix. In A. 
pleuropneumoniae, PGA is responsible for the biofilm formation on polystyrene microtiter 
plates (Izano et al. 2007). PGA plays a role in intercellular adhesion and biofilm formation. 
Detachment and dispersion of A. pleuropneumoniae biofilms can be intiated with dispersin 
B, a glycosyl hydrolase produced by A. actinomycetemcomitans, and A. pleuropneumoniae 
(Kaplan et al. 2004). Interestingly, our laboratory recently reported that biofilm formation 
by A. pleuropneumoniae could be inhibited by low concentrations of zinc (Labrie et al. 
2010).   
6.2 Bordetella bronchiseptica 
 
B. bronchiseptica infections lead to various respiratory syndromes and diseases in a 
wide range of mammals, such as dogs, pigs, cats, rabbits and rats. B. bronchiseptica 
establishes asymptomatic infection, but in pigs, it can cause atrophic rhinitis (Sloan et al. 
2007). B. pertussis and some strains of B. parapertussis are responsible for whooping 
cough in humans. Various respiratory diseases are caused by B. bronchiseptica, and these 
infections are usually chronic. This phenomenon suggest that this organism have specific 
mechanisms to resist host immune responses (Irie et al. 2004).  
 
The survival and persistence of B. bronchiseptica in the mammalian nasopharynx is 
thought to be the result of biofilm formation (Sloan et al. 2007; Conover et al. 2010). B. 
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bronchiseptica can colonize the nasal cavity of the infected host. Detaching cells from a 
biofilm may be responsible for the transmission from one host to another, or the persistence  
of chronic infections if bacteria are inhaled into the lower respiratory tract (Irie and Yulk 
2007).  
 
In Bordetella biofilm development, eDNA is important in maintaining biofilm 
stability (Conover et al. 2011). Bps is a surface polysaccharide of B. pertussis. The Bps 
polysaccharide is similar to the poly-β-1, 6-N-acetylglucosamine polysaccharides. Due to 
its ability to promote biofilm formation, Bps is necessary for colonization of the mouse 
nose and the trachea (Conover et al. 2010).  
6.3 Escherichia coli 
 
E. coli is an important member of the normal intestinal microflora of humans and 
other mammals. E. coli is also an important pathogen causing diarrhea, it leads to the death 
of pigs and occurs worldwide. Enterotoxigenic E. coli (ETEC), producing adhesins that 
mediate bacterial adherence to the intestines and enterotoxins, is the main cause of 
postweaning diarrhea. Enteropathogenic E. coli (EPEC) is another type of E. coli, and 
appears to be associated with about 6% of cases of postweaning diarrhea (Fairbrother et al. 
2005). 
 
Many isolates of E. coli have the ability to form biofilm in vivo and in vitro. Three 
extracellular polysaccharides, cellulose, PGA and colanic acid are major elements of the 
biofilm matrix of E. coli. These polymers are related to the activity of cell-to-cell contacts, 
contributing to the biofilm formation at liquid-solid interfaces, pellicles at air-liquid 
interfaces, cell aggregates and clumps in liquid cultures, and wrinkled colony morphology 
on agar plates (Beloin et al. 2008). PGA is produce by E. coli K-12 and is involved in both 
cell-cell adhesion and formation of permanent attachment to surfaces (Agladze et al. 2005). 
In vivo, when E. coli overexpresses genes required for aggregation and exopolysaccharide 
production, the virulence gene expression is at its highest (Beloin et al. 2008). 
 
 
25 
                                                                                                                                                
6.4 Haemophilus parasuis 
 
H. parasuis, belong to the Pasteurellaceae family, the same family as A. 
pleuropneumoniae. H. parasuis exists commonly in the upper respiratory tract of pigs. This 
pathogen can cause severe systemic disease (Glässer’s disease) under appropriate 
conditions, the characteristic fibrinous polyserositis, polyarthritis and meningitis (Oliveira 
and Pijoan 2004). H. parasuis forms biofilms with variable ability among strains. Only the 
H. parasuis isolated form the nasal cavities of infected pigs could form biofilms. Isolates 
from the lung and brain were unable to form biofilms. This indicates that biofilm formation 
may be associated with persistent infection of H. parasuis in the porcine upper respiratory 
tract. In healthy pigs, H. parasuis can be easily isolated from the upper respiratory tract and 
most isolates are non-virulent. The upper respiratory tract is a suitable biotic surface for the 
biofilm formation by H. parasuis, leading to persistent infection. Pathogenic strains 
isolated from the lung/brain are not able to recover the ability to form biofilm. Non-virulent 
serovars show higher biofilm formation than virulent serovars. The biofilm formation 
phenotype is involved with the recovery site of strains and is maintained when bacteria are 
passaged in vitro and in the upper respiratory tract (Jin et al. 2006).  
6.5 Salmonella 
 
Salmonellosis is an important foodborne disease, it has a significant economical 
impact worldwide. This microorganism commonly infects both human and animals 
(Rabsch et al. 2001). The survival of Salmonella on a polypropylene surface is related to 
the ability to form a biofilm. The extracellular polymeric materials on the polypropylene 
surface can protect the bacterial cells from desiccation. High biofilm producer strains of 
Salmonella survive longer on polypropylene surfaces than the low biofilm producers. Since 
the wide use of plastic materials in food production and cooking, the contamination of 
Salmonella strains on plastic surfaces represents a high risk to food safety (Iibuchi et al. 
2010).  
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Salmonella enterica serovar Typhimurium (S. Typhimurium) is the most frequently 
isolated serovar found in slaughter pigs in Europe. Persistently infected pigs lead to the 
contamination of porcine carcass by S. Typhimurium (Van Parys et al. 2010).  
 
Biofilm formation is influenced by environmental conditions such as temperature 
and the culture medium as well as the origin of the strain. Curli, fimbriae and cellulose 
contribute specifically to the biofilm formation under low nutrient conditions at ambient 
temperatures. The difference in the composition of the biofilm matrix of S. Typhimurium 
grown under conditions mimicking the plant environment and the in vivo environment 
suggest that factors required to prevent biofilms in an industrial setting are different than 
those required to treat an infection (Castelijin et al. 2012). 
6.6 Staphylococcus aureus 
 
Methicillin resistant Staphylococcus aureus (MRSA) colonization in pigs has been 
reported in many regions, such as Europe, North America and Asia. MRSA could be 
transmitted between pigs and humans. Exposure to pigs is the main factor of MRSA 
infection in humans. ST398 MRSA is considered as livestock-associated MRSA, because it 
seems to have originated in pigs, and it could lead to human MRSA infections (Khanna et 
al. 2007; Smith and Pearson 2011; Fitzgerald 2012). In addition, S. aureus is a major 
pathogen of bovine mastitis. Biofilm formation is considered to be an important virulence 
factor in S. aureus. Biofilms produced by S. aureus promote its adherence and colonization 
of the epithelium of the mammary gland (Melchior et al. 2006; Oliveira et al. 2006). 
Biofilm promotes the persistence of Staphylococci in the host tissue and reduces the 
susceptibility to antibiotics (Melchior et al. 2006).  
 
The polysaccharide in Staphylococci, called PIA, is synthesized by enzymes 
encoded by the ica operon. Some strains rely more on the polysaccharide for biofilm 
formation, but other strains form polysaccharide-independent biofilms with matrices that 
contain primarily proteins and eDNA. Biofilms rely on polysaccharides for structural 
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integrity. Some surface proteins such as fibronectin-binding proteins, protein A, SasG, and 
Bap, are associated with cell-cell and cell-surface interactions (Boles and Horswill 2011).  
6.7 Streptococcus suis 
 
Streptococcus suis, a Gram-positive bacterium, is a major pathogen of pigs and it is 
also an emerging zoonotic agent of meningitis and streptococcal toxic shock-like syndrome 
(Fittipaldi et al. 2012). This pathogen is transmitted via respiratory route and colonizes the 
palatine tonsils of pigs. The infections by S. suis result in meningitis, septicemia, arthritis, 
and endocarditis. Among 35 serotypes of S. suis (1 to 34 and ½), serotype 2 is the most 
frequently associated with pathology. The capacity of biofilm formation is restricted to a 
few strains (Grenier et al. 2009). The addition of fibrinogen in the growth medium 
increases biofilm formation by S. suis (Bonifait et al. 2008; Bonifait et al. 2010; Grenier et 
al. 2009).  
 
In S. suis, more biofilm is formed in non-virulent serovar strains than in virulent 
serovars. This indicates biofilm formation might be related to virulence but not the 
character of the virulent strains (Wei et al. 2009). Biofilm cells have lower virulence in an 
animal model, and some virulence genes are down-regulated in biofilm cells. A virulent 
strain may reduce its virulence by forming a biofilm thus resulting in persistent infection in 
vivo (Wang et al. 2011). 
7. Antibiofilm agents 
 
There are different strategies to prevent and inhibit biofilm formation. These 
strategies include the prevention of microbial attachment, prevention of microbial growth, 
disrupting cell-to-cell communication, inhibition of matrix synthesis, and disintegration of 
the biofilm matrix (Landini et al. 2010; Rendueles et Ghigo 2012; Yang et al. 2012). A 
basic strategy to discover inhibitors of biofilm formation is the direct screening of chemical 
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compounds during biofilm formation assays. Molecules can also be evaluated for their 
ability to disperse preformed biofilms. In recent years, the development of target-based 
screening for anti-biofilm agents has been focused on inhibitors of QS (e.g. halogenated 
furanones, azithromycin, 4-nitro-pyridine-N-oxide) and compounds interfering with the 
metabolism of the signal molecule c-di-GMP (e.g. sulfathiazole). Effective antibiofilm 
agents, used in combination or not with antimicrobial agents, could dramatically change the 
treatment of many infectious diseases. Examples of antibiofilm agents reported  in the 
literature are given in Table 1. 
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Table 1. List of Antibiofilm agents. 
Inhibition mechanism Antibiofilm agent References 
Inhibition of  the initial 
adhesion   
Lactoferrin Singh et al. (2002) 
Biosurfactants Rodrigues  (2011) 
  
Modulators of quorum-
sensing signals 
Halogenated furanones Hentzer et al. (2002),     
Muh et al. (2006) 
Azithromycine Nalca et al. (2006), 
Hoffmann et al. (2007) 
4-nitro-pyridine-N-oxide Rasmussen et al. (2005) 
  
Inhibitors of   the 
biosynthesis of c-di-GMP 
Sulfathiazole Antoniani et al. (2010) 
Fluorouracile Walz et al. (2010) 
  
Enzymatic degradation of 
biofilm matrix 
DNase I 
 
Whitchurch et al. (2002), 
Flemming and Wingender 
(2010) 
Dispersine B Kaplan et al. (2003) 
  
Modulation of the quorum-
sensing to promote 
dispersion 
Autoinducing peptide Boles and Horswill (2008) 
cis-2-decenoic acid Davies and Marques (2009) 
D-amino acids Kolodkin-Gal et al. (2010) 
Nitric oxide Hetrick and Schoenfisch 
(2006) 
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8. Zinc 
 
Zinc ion (Zn2+) is the second most abundant trace metal ion in the body. Zinc is an 
indispensable metal for the growth and development for all organisms (Maret 2001). Zinc 
plays a crucial role in several aspects of the immune system, from the barrier of the skin to 
gene regulation within lymphocytes and zinc is also important in the normal development 
and function of cells mediating nonspecific immunity (Shankar and Prasad 1998; Haase and 
Rink 2009).  
 
There are a large number of genes encoding zinc binding proteins, and thus zinc is a 
factor that will influence various biological processes (Devirgiliis et al. 2007). Zinc is 
essential for the normal activity of more than 300 enzymes, including all six classes of 
enzymes. These zinc enzymes are oxidoreductases, transferases, hydrolases, lyases, 
isomerases and ligases. There are three functions in zinc enzymes, such as catalytic, 
coactive and structural. Zinc acts as a catalyst. For example, the enzymes will loss its 
activity when zinc is removed by chelation. For coactive acitivity, zinc atom functions as an 
activator or as an inhibitor when working with another zinc active site in the same enzyme. 
Structural zinc atoms are necessary elements in stabilizing the quaternary structure of 
oligomeric holozymes (Vallee and Falchuk 1993; McCall et al. 2000). In addition, zinc 
could be considered as an intracellular signal (Hasse and Rink 2009). 
 
There are two other zinc-dependent protein groups that have been studied 
intensively: metallothioneins and gene regulatory proteins. Metallothioneins are small 
cytosolic proteins with high cysteine content (25-30%) that can bind zinc with high affinity. 
They belong to the intra-cellular metal-binding proteins, and they are vital factors in zinc-
related cell  homeostasis, including the immune response and protecting cells against 
oxidative stress (Maret 2000; Stefanidou et al. 2006; Devirgiliis et al. 2007). Zinc is a 
functional part in many nucleoproteins that directely participate in replication and 
transcription of DNA (Vallee and Falchuk 1993). 
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Zinc also protects the upper respiratory epithelium which might be related to its 
antioxidant activity. Several factors could contribute to the antioxidant function of zinc. For 
example, zinc only has one oxidation state (II), and zinc reacts poorly with oxidants when 
compared to other metals, such as Fe and Cu (Truong-Tran et al. 2000). 
 
Zinc must be supplied regularly to keep a stable level of bioavailable zinc. Zinc 
deficiency could result  in an increased risk of several  infectious diseases, such as diarrhea, 
pneumonia, malaria as well as skin and wound infections (Walker and Black 2004). 
 
Zinc supplementation improves the treatment and prevention of infectious diseases. 
ZnO has a wide range of antibacterial effects on both Gram-positive and Gram-negative 
bacteria (Raghupathi et al. 2011). However, Roselli et al. (2003) also demonstrated that 
zinc protects intestinal cells from ETEC infection by inhibiting the adhesion and 
internalization of the bacteria. Zinc also prevented an increase in tight junction 
permetability and modulated cytokine gene expression. In addition, our laboratory 
demonstrated that zinc could inhibit biofilm formation of A. pleuropneumoniae in a dose-
dependent manner (Labrie et al. 2010). In some chronic infections, bacteria hide in a 
protective biofilm, making them both more persistent and less invasive (Parsek and Singh 
2003). 
 
Feeding higher concentration of zinc to pigs may result in the production of manure 
with a higher concentration of zinc which may lead to the environmental problem (Carlson 
et al. 2004). Zinc supplementation with MMT (montmorillonite, a controlled-release carrier 
for drug molecules and for gene delivery) improved pig performance, alleviated 
postweaning diarrhea and enhanced intestinal mucosal integrity and the active of digestive 
enzyme in the pancreas and small intestinal (Hu et al. 2012). 
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III. Approach and scientific steps 
 
Biofilm formation by bacterial pathogens is important for the transmission of 
infections and persistence of bacteria in hostile environments. Furthermore, bacteria grown 
as a biofilm are protected against a variety of environmental stresses such as antibiotics, 
disinfectants and host defence. A metal cation (zinc) has been  previously shown by our 
laboratory to inhibit biofilm formation of A. pleuropneumoniae (Labrie, et al. 2010). We 
propose in this work to evaluate the antibiofilm potential of zinc on other bacterial swine 
pathogens. 
 
Thus, the aim of this project is to evaluate the effect of zinc on growth and biofilm 
formation of important bacterial pathogens of swine. Biofilms will be studied in the 96-well 
polystyrene plates under optimal conditions for biofilm formation. Biofilms will be stained 
with crystal violet and quantified by measuring the absorbance at 590 nm. Confocal laser 
scanning microscopy will be used to visualize biofilm stained with FilmTracerTM FM® 1-
43, a fluorescent marker of the cell membrane. Varying concentration of zinc will be added 
to the biofilm-formation medium to measure the inhibitory effect of zinc on biofilm 
formation. Florescent molecules, which include Wheat Germ Agglutinin, FilmTracerTM 
SYPRO® Ruby or BOBOTM 3 iodide will be used to stain PGA, extracellular protein and 
eDNA in biofilm matrix, separately. If zinc can inhibit biofilm formation of most of the 
pathogens tested, zinc could therefore be a potential antibiofilm agent in combination with 
antibiotic or disinfectant treatments. 
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IV. Methods and Results 
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ABSTRACT  
 
Aims: Biofilm formation is important for the persistence of bacteria in hostile 
environments. Bacteria in a biofilm are usually more resistant to antibiotics and 
disinfectants than planktonic bacteria. Our laboratory previously reported that low 
concentrations of zinc inhibit biofilm formation of Actinobacillus pleuropneumoniae. The 
aim of this study is to evaluate the effect of zinc on growth and biofilm formation of other 
bacterial swine pathogens. Methods and Results: To determine the effect of zinc on 
biofilm formation, biofilms were grown with or without zinc in 96-well plates and stained 
with crystal violet. At micromolar concentrations (0 – 250 µM), zinc weakly inhibited 
bacterial growth and it effectively blocked biofilm-formation by A. pleuropneumoniae, 
Salmonella Typhymurium, and Haemophilus parasuis in a dose-dependent manner. 
Additionally, biofilm formation of Escherichia coli, Staphylococcus aureus and 
Streptococcus suis was slightly inhibited by zinc. However, zinc did not disperse preformed 
biofilms. To determine if zinc inhibits biofilm formation when poly-N-acetylglucosamine 
(PGA) is present, PGA was detected with the lectin wheat germ agglutinin. Only A. 
pleuropneumoniae and S. aureus biofilms were found to contain PGA. Conclusion: Zinc 
used at non-bactericidal concentrations can inhibit biofilm formation by several Gram-
negative and Gram-positive bacterial swine pathogens. Significance and Impact of Study: 
The antibiofilm activity of zinc could provide a tool to fight biofilms and the non-specific 
inhibitory effect may well extend to other important human and animal bacterial pathogens. 
 
Key words:  zinc, biofilm, matrix, bacterial pathogens, swine 
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1. Background 
Biofilms are a structured community of microorganisms enclosed in a self-produced 
extracellular polymer matrix adhered to biological or non-biological surfaces (Costerton et 
al. 1999). In nature, bacteria predominantly exist in a sessile form (biofilm) rather than a 
free-swimming form (planktonic) (O'Toole et al. 2000, Stoodley et al. 2002). The biofilm 
matrix is responsible for adhesion to surfaces and for cohesion in the biofilm, and may 
contain polysaccharides, proteins, and extracellular DNA (eDNA). The composition of the 
matrix varies greatly between different microorganisms (Flemming and Wingender 2010). 
Biofilm formation by bacterial pathogens is important for the transmission of infections and 
persistence of bacteria in hostile environments (Hall-Stoodley et al. 2004, Lewis 2010). 
Furthermore, bacteria grown as a biofilm are protected against a variety of environmental 
stresses such as antibiotics, disinfectants and host defences (Hall-Stoodley and Stoodley 
2009, Hoiby et al. 2010, Bridier et al. 2011). 
 
 The negative impact of biofilm formation by pathogens of medical and veterinary 
importance on the efficacy of antibiotics and disinfectants is a major problem in animal and 
human health (Parsek and Singh 2003, Clutterbuck et al. 2007, Jacques et al. 2010). Due to 
the general properties of biofilms, the prevention, diagnosis and treatments of diseases 
associated with biofilms require novel approaches. The discovery and development of 
agents with the ability to limit biofilm formation or eradicate established biofilms would 
have the potential to enhance the efficacy of biocides that are relatively ineffective against 
biofilm bacteria (for recent reviews see (Rendueles et al. 2013, Worthington et al. 2012). 
Furthermore, there is a growing interest in the discovery of nonbiocidal antibiofilm 
molecules because the selective pressure on bacteria to develop resistance to nonbiocidal 
agents should be significantly reduced.  
 
Our laboratory recently reported that low concentrations of zinc inhibit biofilm 
formation by Actinobacillus pleuropneumoniae (Labrie et al. 2010).  A. pleuropneumoniae 
is the Gram-negative bacterium responsible for porcine pleuropneumonia, a respiratory 
disease of swine (Chiers et al. 2010). Biofilm formation by A. pleuropneumoniae on 
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polystyrene microtiter plates is dependent on the production of PGA, a polymer of β-1, 6-
N-acetyl-D-glucosamine (Kaplan et al. 2004). Biofilm formation has also been 
demonstrated in other swine pathogen including Bordetella bronchiseptica, Escherichia 
coli, Haemophilus parasuis, Salmonella Typhymurium, Staphylococcus aureus, and 
Streptococcus suis (Jacques et al. 2010). The observation we made concerning the 
antibiofilm activity of zinc is of interest because zinc supplementation has been associated 
with the reduction of diarrheal and respiratory diseases in humans and in animals 
(Aggarwal et al. 2007, Crane et al. 2011, Molist et al. 2011) and is frequently added to 
piglet feed (Molist et al. 2011, Shelton et al. 2011). 
 
Thus, the aim of the present study was to evaluate the effect of zinc on bacterial 
growth and biofilm formation of other important swine pathogens. 
 
2. Materials and Methods 
 
2.1 Bacterial strains 
All strains used in this study are listed in Table 1. A. pleuropneumoniae was grown 
on Brain Heart Infusion (BHI; Oxoid Ltd, Basingstoke, Hampshire, UK) agar 
supplemented with 15 µg/mL nicotinamide adenine dinucleotide (NAD). Bordetella 
bronchiseptica, Haemophilus parasuis, Salmonella, Staphylococcus aureus, Streptococcus 
suis were grown on BHI agar. Escherichia coli strains were grown on Luria-Bertani (LB; 
Becton, Dickinson and Company, Sparks, MD, USA) agar. Plates were incubated overnight 
at 37ºC with 5% CO2.  
 
2.2 Biofilm assay  
Growth conditions to obtain mature biofilms for the assay are summarized in Table 
2. Briefly, overnight cultures of A. pleuropneumoniae, B. bronchiseptica, E. coli, 
Salmonella, S. aureus, or S. suis were diluted 1/100 in their corresponding broth and a 
volume (100 µL) was aliquoted in triplicate in a flat-bottom 96-well polystyrene plate. For 
H. parasuis, colonies from overnight agar cultures were resuspended in BHI and the 
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suspension was aliquoted (100 µL) in triplicate in a flat-bottom 96-well polysterene plate. 
With the exception of E. coli, the microtiter plate used was a Costar® 3599 96-well plate 
(Corning, NY, USA). For E. coli, Costar® 3370 96-well plates (Corning) were used. Wells 
containing sterile broth were used as negative control.  
  
Following incubation (Table 2), biofilms were treated as described by Labrie et al. 
(2010) with some modifications. Briefly, the liquid medium was removed using a vacuum 
and unattached cells were removed by immersing the plate once in MilliQ water. The water 
was removed with a vacuum and excess water was removed by inverting plates onto a 
paper towel. Biofilms were then stained with 0.1% (w/v) crystal violet for 2 min. Biofilms 
were washed once with distilled water and then dried at 37°C for 15 min. The stain was 
then released with 100 µL of 70% (v/v) ethanol and the amount of released stain was 
quantified by measuring the absorbance at 590 nm with a microplate reader (Powerwave, 
BioTek Instruments, Winooski, VT, USA). Unstained replicate plates were used to evaluate 
growth by measuring the absorbance at 600 nm. 
 
2.3 Confocal laser scanning microscopy (CLSM) 
Biofilms were prepared as described above. After the desired incubation time (Table 
2), biofilms were stained with FilmTracerTM FM® 1-43 fluorescent marker (Molecular 
Probes, Eugene, OR, USA) according to manufacturer’s instructions. To determine the 
composition of the biofilm matrix, biofilms were stained with Wheat Germ Agglutinin 
(WGA-Oregon Green 488, Molecular Probes), FilmTracerTM SYPRO® Ruby biofilm 
matrix stain (Molecular Probes) or BOBOTM-3 iodide (Molecular Probes) according to 
manufacturer’s instructions. After a 30 min incubation at room temperature, the fluorescent 
marker solution was removed, biofilms were washed with water and the wells were then 
filled with 100 µL of water or PBS for WGA-stained biofilms. Stained biofilms were 
visualized by CLSM (Olympus FV1000 IX81, Markham, ON, Canada). 
  
2.4 Effect of zinc on biofilm formation 
Biofilms were prepared as described above with some modifications. Prior to 
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inoculation, varying concentration of zinc was added to the biofilm medium by adding an 
identical volume of serial dilutions of a stock solution of ZnCl2 or ZnO in water. With the 
exception of S. suis, 0, 100, 250, 500, 750, or 1000 µM of zinc was added to the biofilm 
medium. Since S. suis growth was more sensitive to zinc, 0, 50, 100, 150, 200, or 250 µM 
of zinc was added. The biofilms were incubated as described in Table 2 and were processed 
as described in section 2.2.  
 
2.5 Dispersion of preformed biofilms by zinc 
Biofilms were prepared as described in section 2.2. After the desired incubation 
time, the biofilms were washed with water and aliquots (100 µL) of growth medium 
containing different concentration of ZnCl2 (0, 100, 250, 500, 750, or 1000 µM) were 
added to preformed biofilms. The biofilms were incubated for an additional 24 hours in the 
presence of ZnCl2. Biofilms were then stained with crystal violet as described above. 
Dispersion was measured by comparing the amount of biofilm in the control and treated 
well. A biofilm was considered dispersed if the amount of the amount zinc-treated biofilm 
was significantly reduced. 
 
2.6 Statistical analysis 
The effect of zinc concentration on the percent biofilm formation from the untreated 
control were compared with one-way analysis of variance (ANOVA) taking into account 
the bacterial growth and considering the runs of the ELISA as random effects (package 
lme4 [Bates et al., 2011] of R statistical software [R Development Core Team, 2012]). 
Multiple comparisons to the control concentration were realized by Dunnett's test. 
 
3. Results 
 
3.1 Biofilm formation 
3.1.1 Optimal conditions for biofilm formation 
In this study, optimal conditions for biofilm formation by different bacterial swine 
pathogens were determined based on information available in the literature (Table 2). The 
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incubation period were selected to yield mature biofilms for each species. For E. coli and 
Salmonella, the bacteria need to be incubated at 30ºC to form biofilms. The other species 
were able to form mature biofilms at 37ºC. The typical time of incubation was 24h but 
Salmonella and H. parasuis required 48h to form a mature biofilm whereas 5h was 
sufficient for A. pleuropneumoniae to form a mature biofilm. With the exception of E. coli, 
every species formed a biofilm in a polystyrene microtiter plate that was treated for tissue 
culture (TC) (Costar® 3599). E. coli did not form biofilms on the TC treated polystyrene 
and required non-treated polystyrene to form biofilms (Costar® 3370). Biofilm formation 
for all bacteria was tested first in BHI. Most bacteria formed biofilms in BHI, however E. 
coli, S. suis and Salmonella required the defined minimal media M9, Basal Broth medium 
(BBM) and Colonization Factor Antigen medium, respectively. Finally, the S. aureus and S. 
suis biofilm-medium required supplementation with glucose and fibrinogen, respectively, to 
form robust biofilms.  
 
3.1.2 Typical biofilm assay results 
Biofilm formation was assayed using a static microtiter plate assay and by staining 
the biofilm with crystal violet (Table 3).  In a typical assay, A. pleuropneumoniae and S. 
suis strains were the strongest biofilm producers with an average A590 of dye that ranged 
from 1 to 3, followed by E. coli, S. Typhimurium and S. aureus with A590 ~1.0.  B. 
bronchiseptica, H. parasuis and S. Heidelberg were the weakest biofilm formers with an 
average A590 ranging from 0.34 to 0.77.  
 
3.1.3 Confocal laser scanning microscopy 
To confirm the results obtained with the crystal violet assay, biofilms were 
visualized by CLSM. The biofilms were stained with FilmTracerTM FM® 1-43, a molecule 
that becomes fluorescent once it is inserted in the cell membrane. Biofilm structure 
characteristics varied among the different bacterial species. Representative CLSM images 
of the different biofilms are shown in Figure 1. To further characterize the biofilms, 15 
images of biofilm layers were recorded and stacked, and 3D-images of the biofilms were 
generated (Fig. 2A). Based on these reconstructions, the thickness of the biofilm produced 
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by each bacterial species was evaluated. The thickness of A. pleuropneumoniae serotype 5b 
strain L20 biofilm was around 60 µm (Fig. 2B). The biofilm thickness for the other 
bacterial species ranged from 20 µm to 40 µm (Table 2).  
 
3.2 Effect of zinc on biofilm formation 
Once growth conditions for optimal biofilm formation were determined, the effect 
of different zinc (ZnCl2) concentration on biofilm formation was assessed (Fig. 3). To test 
the relationship between the effect of zinc on bacterial growth and biofilm formation, A600 
was recorded to assess the growth of the bacteria and, with a replicate plate, crystal violet 
staining was measured to assess the amount of biofilm formed. For the purpose of statistical 
analyses, the values were transformed so that they are represented as the percentage of the 
no-treatment (without zinc) control. Similar results were obtained with ZnO and are, 
therefore, not shown. 
 
3.2.1 A. pleuropneumoniae 
Zinc inhibited biofilm formation by A. pleuropneumoniae in a dose dependent 
manner as previously shown by our group (Labrie et al. 2010; Fig. 3A). Zinc treatment up 
to 250 µM did not affect bacterial growth. However, biofilm formation by A. 
pleuropneumoniae was significantly decreased (p<0.001), when the same concentration of 
zinc (250µM) was added.  
 
3.2.2 B. bronchiseptica 
Zinc did not have any effect on bacterial growth and on biofilm formation of B. 
bronchiseptica strain 276 (Fig. 3B).  
 
2.2.3 E. coli 
When zinc was added, a significant decrease (p< 0.001) in biofilm formation was 
observed for E. coli (Fig. 3C). However, the amount of biofilm was ~50% of the no-
treatment control. Bacterial growth was reduced to at least 80% of the control at 100, 250, 
and 500 µM (see Fig. 3C). Therefore, zinc was considered to have a slight effect on E. coli 
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biofilm formation. 
 
3.2.4 H. parasuis  
Biofilm formation by H. parasuis was significantly reduced (p<0.001) at a 
concentration as low as 100 µM of ZnCl2 (Fig. 3D). At higher concentrations (250 µM-
1000 µM), the percentage of biofilm formation was stable at ~40% of the no-treatment 
control. Furthermore, zinc did not have a bactericidal effect (Figure 3D).  
 
3.2.5 S. Typhimurium  
S. Typhimurium formed significantly (p<0.001) less biofilms in the presence of 
zinc. At lower concentrations (100 and 250µM), biofilm formation was reduced to ~60% 
(p<0.001) and bacterial growth was reduced to ~80% of the control (Fig. 3E). At higher 
concentrations of zinc, there was almost no biofilm formed and growth remained at ~80% 
of the control (Fig. 3E).  
 
3.2.6 S. Heidelberg 
In the case of S. Heidelberg, zinc decreased biofilm formation compared to the no-
treatment control but a similar decrease was observed in bacterial growth (Fig. 3F). 
Therefore, the effect of zinc on biofilm formation was not considered to be significant.  
 
3.2.7 S. aureus 
Unlike most bacteria tested, biofilm formation by S. aureus seemed stimulated in 
the presence of 100 µM of zinc (Fig. 3G). Biofilm formation was reduced to 80% of the 
control when 500 µM ZnCl2 was added (p<0.001). Bacterial growth was slightly affected 
by zinc. Therefore, high concentrations of zinc slightly decreased biofilm formation by S. 
aureus. 
 
3.2.8 S. suis 
Growth of S. suis was more sensitive to zinc when compared to the other bacterial 
swine pathogens tested. A significant (p<0.001) reduction in biofilm formation was 
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observed at 150µM ZnCl2 (Fig. 3H). At 200µM ZnCl2, S. suis biofilm formation was 
completely inhibited but growth was also markedly affected. Despite the effect of zinc on 
growth, we concluded that zinc had a significant effect on biofilm formation of S. suis at 
higher concentrations of zinc. 
 
3.2.9 Inhibitory effect of zinc confirmed by CLSM 
To confirm the inhibitory effect of zinc on biofilm formation, we used CLSM and 
fluorescent staining to visualize the zinc-treated and control biofilms. Biofilm formation by 
S. Typhimurium in the presence of ZnCl2 is shown as an example (Fig. 4). As observed with 
the microtiter plate assay and crystal violet staining, S. Typhimurium formed markedly less 
biofilm than the control when grown in the presence of 250 and 500 µM of ZnCl2 (Fig. 4).  
 
3.3 Effect of zinc on dispersion of preformed biofilms 
The ability of zinc to disperse preformed biofilms was also evaluated. The addition 
of zinc (ZnCl2) followed by an additional incubation for 24h did not result in a reduction in 
the amount of biofilm when compared to the control biofilm. Therefore, it was concluded 
that zinc did not disperse preformed biofilms (data not shown). 
 
3.4 Composition of biofilm matrix 
The matrix of the different biofilms was stained with fluorescent probes specific for 
poly-N-acetyl-D-glucosamine (PGA) (Wheat Germ Agglutinin), eDNA (BOBOTM-3 iodide) 
and proteins (FilmTracerTM SYPRO® Ruby). The composition of the matrix for the 
different bacterial pathogens is summarized in Table 4. The biofilm matrices of A. 
pleuropneumoniae and S. aureus were positive for all three components (PGA, eDNA and 
proteins) whereas B. bronchiseptica was negative for all three (Fig. 5; Table 4). E. coli was 
also negative for the three components and H. parasuis and S. Heidelberg were only 
positive for eDNA. Both S. suis and S. Typhimurium were positive for eDNA and proteins. 
 
4. Discussion 
Given that biofilm-associated infections are often chronic and difficult to eradicate, 
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the identification of anti-biofilm molecules is of high importance (Hall-Stoodley and 
Stoodley 2009, Jacques et al. 2010). The use of metal ions to eradicate biofilms has 
received some attention (Harrison et al. 2005, Workentine et al. 2008). The potential of zinc 
as anti-biofilm molecule has not been fully explored but recent study have demonstrated 
that biofilms of enteroaggregative E. coli (EAEC; Pereira et al. 2010), uropathogenic E. 
coli (UPEC; Hancock et al. 2010) and dental plaque bacteria (Gu et al., 2012) were 
sensitive to zinc. Furthermore, our laboratory previously demonstrated that sub-bactericidal 
concentration of zinc could inhibit biofilm formation of the swine pathogen, A. 
pleuropneumoniae (Labrie et al. 2010). The objective of our study was to evaluate the 
effect of zinc on biofilm formation of other important bacterial swine pathogens including 
B. bronchiseptica, E. coli, H. parasuis, Salmonella, S. aureus and S. suis. Under optimal 
conditions for biofilm formation, the addition of sub-bactericidal concentration of zinc 
(ZnCl2 or ZnO) effectively blocked biofilm-formation of A. pleuropneumoniae, S. 
Typhymurium, and H. parasuis in a dose-dependent manner. Additionally, biofilm 
formation of E. coli, S. aureus and S. suis was slightly inhibited by the presence of zinc. 
 
In our study, zinc was able to inhibit the biofilm formation of both intestinal and 
respiratory pathogens. Furthermore, the use of zinc to reduce diarrheal and respiratory 
diseases in humans and animals has already been demonstrated (Aggarwal et al. 2007, 
Crane et al. 2011, Molist et al.. 2011). Thus, the reduction of intestinal and respiratory 
diseases by zinc can probably be attributed to both the antimicrobial and antibiofilm 
activity of zinc. In addition to preventing infectious diseases, zinc supplementation has 
been used in the diet of pigs to improve feed intake. For example, ZnO supplementation 
altered the development of the small intestine mucosa of weaned pigs (Slade et al. 2011) 
and improved feed intake and growth of piglets (Molist et al. 2011). Additionally, the 
combination of an antibacterial agent and ZnO supplementation lead to an improvement of 
performance markers (Hill et al. 2001). In combination with our data, these indicate the 
clinical value of zinc as an additive in diet of pigs. Furthermore, it highlights the possibility 
that zinc may act synergistically with biocides. 
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Synergic effects of metal ions and biocides on biofilms have also been investigated. 
For example, when copper was combined with quaternary ammonium cations, synergistic 
bactericidal and antibiofilm activity was observed against Pseudomonas aeruginosa 
(Harrison et al. 2008). This suggested that zinc could increase the effectiveness of 
disinfectants. If such phenomenon is observed, zinc could be used with other disinfectant to 
control environmental biofilms in the farm and food-processing plants. Environmental 
biofilms are important in the persistence of bacterial pathogens, such as E. coli and Vibrio 
cholera (Shikuma and Hadfield 2010). 
 
Despite our positive results, the use of zinc may face some limitation given that 
bacterial evolution is a fairly rapid process. For example, the use of zinc could apply 
selective pressure for strain that are able to form biofilm in the presence of antibiofilm 
concentration of zinc. Furthermore, a selection pressure could also be applied on pathogens 
to increase the subpopulations that do not form biofilm. In our study, strains from a species 
respond similarly to presence of zinc; however, a larger set of isolates representing different 
genotype should be included in future studies to ensure that antibiofilm effect of zinc is not 
genotype specific within a species. 
 
The mechanism behind the antibiofilm activity of zinc has yet to be characterized, 
but zinc could interact with components of the matrix.  It has been recently reported that 
PgaB activity, involved in de-N-acetylation of E. coli PGA, is decreased by zinc (Little et 
al. 2012). However, in our study, only A. pleuropneumoniae and S. aureus biofilms were 
found to contain PGA. Under our experimental conditions, species that did not produce 
PGA were also inhibited, indicating that the inhibitory effect of zinc does not appear to be 
solely dependent on the presence of PGA in the biofilm matrix. eDNA was one component 
that was present in most of the biofilm matrices. eDNA can act as a zinc chelator and this 
interaction has an impact on biofilm stability (Mulcahy et al. 2008). Zinc may also interfere 
with other cellular mechanisms such as signalling and gene-regulation. Zinc can bind to the 
ferric uptake regulator and may affect iron homeostasis (Klemm et al. 2010). Zinc can also 
interfere with a toxin-antitoxin (TA) system, MqsR/MqsA, which is associated with biofilm 
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formation and the development of persister cells (Papadopoulos et al. 2012). Homologues 
to this TA system are found in many pathogenic bacteria (Gerdes et al. 2005). Finally, zinc 
can inhibit the EAL domains of cyclic diguanylate phosphodiesterases and this inhibition 
blocks the degradation of c-di-GMP (Tamayo et al. 2005, Jenal and Malone 2006). c-di-
GMP is an important player in the regulation of biofilm formation and interference in the c-
di-GMP pathway will likely have consequences on the biofilm formation process (Jonas et 
al., 2009).  
 
In conclusion, micromolar concentrations of zinc can inhibit biofilm formation by 
several Gram-negative and Gram-positive bacteria of porcine origin. The mechanism 
behind the antibiofilm activity of zinc has yet to be characterized. It does not, however, 
appear to be solely dependent on the presence of PGA in the biofilm matrix as initially 
thought. Given that zinc is a simple and inexpensive molecule, it would be worth to test if 
synergic effects are observed with antibiotic and disinfectant treatments, and thus reduce 
the virulence, persistence and transmission of pathogenic bacteria. In addition, the non-
specific inhibitory effect of zinc on biofilm formation may well extend to other important 
human and animal bacterial pathogens. 
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Table 1. Bacterial strains used in this study. 
Bacterial species Strains Relevant traits Inhibitory concentration Source 
ZnCl2 ZnO 
Actinobacillus 
pleuropneumoniae 
S4074 serotype 1; reference strain 1000 µM 1000 µM K.R.Mittal1 
 719 serotype 1 750 µM 7500 µM D. Slavic2 
 L20 
 
serotype 5b;  reference strain 
 
1000 µM 1000 µM K.R. Mittal 
Bordetella bronchiseptica 276 
 
 >1000 µM >1000 µM J.M. Rutter3 
Escherichia coli ECL 17608 STb: AIDA: EAST1 >1000 µM >1000 µM J. M. Fairbrother1 
 ECL 17659 F18: AIDA >1000 µM >1000 µM J. M. Fairbrother 
 ECL 17635 
 
Eae: Paa >1000 µM >1000 µM J. M. Fairbrother 
Haemophilus parasuis Nagasaki serotype 5; reference strain >1000 µM >1000 µM M. Gottschalk1 
Salmonella Typhimurium ATCC 14028      >1000 µM >1000 µM A. Letellier1                     
STF07-8567-3 
 
>1000 µM >1000 µM A. Letellier 
Salmonella Heidelberg STF08-453 
 
 >1000 µM >1000 µM A. Letellier 
Staphylococcus aureus 154N methicillin resistant;  nasal isolate >1000 µM >1000 µM M. Archambault1 
 294 methicillin resistant; skin isolate >1000 µM >1000 µM M. Archambault 
 327N methicillin resistant;  nasal isolate 
 
>1000 µM >1000 µM M. Archambault 
Streptococcus suis 735 serotype 2; reference strain 250 µM 250 µM M. Gottschalk 
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1 Faculté de médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC, Canada. 
2 Ontario Veterinary College, University of Guelph, Guelph, ON, Canada. 
3 Institute for Research on Animal Disease, Compton, UK. 
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Table 2. Growth conditions used for each bacterial species to obtain mature biofilms. 
Bacterial Species Growth Conditions Corning 
Plate ID 
Incubation 
temperature and 
atmosphere 
Incubation 
time 
Reference 
A. pleuropneumoniae O/N in 5mL of BHI with NAD (5 μg/mL) at 37ºC with 
shaking (200 rpm); dilution 1/100 in BHI with NAD (5 
μg/mL) 
 
3599 37ºC, 5% CO2 5h Labrie et al. 2010 
B. bronchiseptica O/N in 5mL of BHI at 37ºC with shaking (200 rpm); 
dilution 1/100 in BHI 
 
3599 37ºC, 5% CO2 24h This study 
E. coli O/N in 5mL of M9 minimal medium at 30ºC with shaking 
(200 rpm); dilution 1/100 in M9 minimal medium 
 
3370 30ºC 24h Charbonneau et al. 2006 
H. parasuis Resuspend colonies from a BHI agar plate in 3mL of BHI 
 
3599 37ºC, 5% CO2 48h This study 
Salmonella O/N in 5mL of Colonization Factor Antigen (CFA) 
medium at 37ºC with shaking (200 rpm); dilution 1/100 in 
CFA 
 
3599 30ºC 48h Suzuki et al. 2002 
S. aureus O/N in 5mL of BHI with glucose (0.25% [w/v]) at 37ºC 
with shaking (200 rpm); dilution 1/100 in BHI with 
glucose (0.25% [w/v]) 
 
3599 37ºC, 5% CO2 24h This study 
S. suis O/N in 5mL of Basal Broth Medium (BBM) with 
fibrinogen (5 mg/mL) at 37ºC with shaking (200 rpm); 
dilution 1/100 in BBM with fibrinogen   (5 mg/mL) 
3599 37ºC, 5% CO2 24h Bonifait et al. 2008 
 
 
56 
                                                                                                                                                
Table 3. Biofilm formation in a microtiter plate. 
Bacterial strains 
Range of OD590 nm 
after staining with 
crystal violet 
Biofilm thickness 
(in µm) as 
determined by 
CLSM 
 
A. pleuropneumoniae S4074 
 
1.85±0.24 35 
 
B. bronchiseptica 276 
 
0.60±0.27 25 
 
E. coli ECL 17608 
 
1.04±0.07 23 
 
H. parasuis Nagasaki 
 
0.77±0.47 20 
 
S. Typhimurium ATCC 14028 
 
0.99±0.17 21 
 
S. Heidelberg STF08-453 
 
0.34±0.10 20 
 
S. aureus 154N 
 
1.09±0.63 40 
 
S. suis 735 
 
2.63±0.26 35 
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Table 4. Composition of the biofilm matrix as determined by staining and CLSM. 
 Component 
Bacterial strains 
PGA 
 (WGA) 
Extracellular DNA 
(BOBO-3) 
Protein 
 (SYPRO Ruby) 
A. pleuropneumoniae S4074 + + + 
B. bronchiseptica 276 - - - 
E. coli ECL 17608 - - - 
H. parasuis Nagasaki - + - 
S. Typhimurium ATCC 14028 - + + 
S. Heidelberg STF08-453 - + - 
S. aureus 154N + + + 
S. suis 735 - + + 
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Figure 1. CLSM of FilmTracerTM FM® 1-43 stained biofilms of A. pleuropneumoniae 
S4074 (A), B. bronchiseptica 276 (B), E. coli ECL17608 (C), H. parasuis Nagasaki (D),  S. 
Typhimurium ATCC14028 (E), S. Heidelberg STF08-453 (F), S. aureus 154N (G), S. suis 
735 (H). 
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Figure 2. CLSM three-dimensional images of biofilm formation by A. pleuropneumoniae 
strain L20 stained with FilmTracerTM FM® 1-43 (A) and stack of sections of the X-Z plane 
of the biofilm (B).   
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Figure 3. Effect of ZnCl2 on the formation of biofilm and growth of A. pleuropneumoniae 
S4074 (A), B. bronchiseptica 276 (B), E. coli ECL17608 (C), H. parasuis Nagasaki (D), S. 
Typhimurium ATCC14028 (E), S. Heidelberg STF08-453 (F), S. aureus 154N (G), S. suis 
735 (H). Values are represented as percentage of the no-treatement control. Box and 
whisker plots represent biofilm formation and the diamonds represent bacterial growth. 
Black dots outside the box and whiskers are considered outliers. Statistical significance was 
established by analysis of variance (ANOVA). Multiple comparisons to the control 
concentration were realized by the Dunnett's test. * P<0.01; ** P<0.001. 
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Figure 4. CLSM images of S. Typhimurium ATCC 14028 biofilms grown in the presence of 
different ZnCl2 concentrations (0:A, 250:B or 500 µM:C). Biofilms were stained with 
FilmTracerTM FM® 1-43. 
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Figure 5. CLSM images of the biofilm matrix of A. pleuropneumoniae S4074 (A) and B. 
bronchiseptica 276 (B) stained with FilmTracerTM FM® 1-43, Wheat Germ Agglutinin 
(WGA) conjugated to Oregon Green 488, BOBO-3TM and FilmTracerTM SYPRO Ruby. 
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V. Discussion 
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Bacteria that attach to biotic and non-biotic biological surfaces can form biofilms. 
Biofilm infections are considered to be a major problem in clinical settings because 
biofilms are hard to eradicate (Costerton et al. 1999). Biofilms often result in chronic 
infections, and are resistant to the host immune response and antibiotic treatment. All these 
factors enable pathogens to persist (Hall-Stoodey and Stoodley 2009).  
 
A large number of studies have focused on biofilm infections of humans. For 
example, the organism is found in the lesions of the disease and can be isolated in pure 
culture on artificial media; a similar symptom would be seen by inoculating the culture in 
experimental animals; from the lesions of infected animals, the organism can be recovered 
(Donlan and Costerton 2002). Unfortunately, few studies on biofilm in animal diseases 
have been published (Clutterbuck et al. 2007; Jacques et al. 2010). Persistent microbial 
contaminations resulting from biofilm formation have lead to food spoilage or disease 
transmission in food-processing environments (Van Houdt and Michiels 2010). Biofilm 
infections induce morbidity and mortality associated with various diseases due to their 
reduced susceptibility to antibiotics and this represents a serious threat to society. The 
prominence of biofilm in infectious disease requires intense research on the development of 
anti-biofilm molecules that have different mode of action than antibiotics or microbicides. 
Such molecules should be able to modulate bacterial biofilm formation resulting in the 
inhibition of biofilm-associated infections (Worthington et al. 2012). 
 
The administration of zinc is a useful tool for the treatment and prevention of 
several diseases of humans and animals, especially those that occur at epithelial sites. Zinc 
supplementation effectively reduced the frequency and severity and duration of diarrhea 
and respiratory illnesses (Aggarwal et al. 2007). The inclusion of ZnO in the diet of post-
weaning piglets improved their feed intake and growth, and reduced the incidence of 
diarrhea (Molist et al. 2011). In addition, our laboratory demonstrated that zinc could 
inhibit biofilm formation of A. pleuropneumoniae in a dose-dependent manner (Labrie et al. 
2010). Considering that zinc has inhibitory effect on biofilm formation by A. 
pleuropneumoniae and that zinc is used to reduce disease burden on farms, we were 
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interested in evaluating the effect of zinc on biofilm formation of other important bacterial 
pathogens of swine including B. bronchiseptica, E. coli, H. parasuis, Salmonella, S. aureus 
and S. suis. 
 
After determining the optimal conditions for biofilm formation, biofilm formation 
was evaluated using a 96-well plate and biofilms were stained with crystal violet. The 
presence of reproducible biofilms was confirmed by CLSM. CLSM was used to visualize 
the biofilms and get a better understanding of biofilm structure and thickness. CLSM is a 
great tool for biofilm analysis because it allows the study of living, and fully hydrated 
biofilms (Denkhaus et al. 2007). Three dimensional (3D) structure of biofilm revealed the 
typical mushroom shape and a network of water channels for distribution of water and 
nutrients in the community (Stoodley et al. 2002). In addition, the mean thickness of 
biofilm is an important parameter for describing the structure of biofilms (Beyenal et al. 
2004).  
 
The effect of zinc on biofilm formation was evaluated. Zinc was added in the 
growth culture at the beginning of the biofilm formation. Zinc (ZnCl2 or ZnO) weakly 
inhibited bacterial growth at micromolar concentrations (0 – 250 µM) indicating that it 
possesses antimicrobial activity. At micromolar concentrations, zinc was able to effectively 
block biofilm formation of A. pleuropneumoniae, S. Typhymurium, and H. parasuis in a 
dose-dependent manner. Additionally, biofilm formation of E. coli, S. aureus and S. suis 
was slightly inhibited by the presence of zinc. At low concentration (100 µM to 150 µM), 
the addition of zinc resulted in reduction in biofilm formation and bacterial growth, 
suggesting that the S. suis strain was more sensitive to zinc than the other pathogens tested.  
 
Zinc supplementation has been reported as beneficial in previous studies, and zinc 
has an inhibitory effect on biofilm formation of some pathogenic bacteria. Therefore, the 
reduction in intestinal and respiratory diseases burden associated with zinc could be 
attributed to both its antimicrobial and antibiofilm activity. The addition of zinc results in 
the reduction in Shiga-toxigenic enteropathogenic E. coli (STEC) infections (Crane et al. 
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2011). Zinc has also a strong inhibitory effect on Stx expression which is responsible for 
the extraintestinal symptoms associated with STEC infection. Furthermore, Zn (II) could 
significantly reduce attachment and biofilm formation of urinary tract E. coli. The addition 
of Zn (II) (500μM) impaired biofilm formation in microtiter plate. Biofilms formed in flow 
cell chamber system, which mimic conditions encountered in urinary tract, were affected 
more by Zn (II) than the biofilms formed in a microtiter plate (Hancock et al. 2010). In 
addition, zinc has a significant antibacterial effect on the outer and middle layers of dental 
plaque, a good example of an in vivo biofilm. Zinc could be a potential and effective 
supplement in dentifrices and mouth rinses to combat dental plaque (Gu et al. 2012).  
 
The mechanism behind the antibiofilm activity of zinc has yet to be characterized, 
but zinc could interact with components of the biofilm matrix. For example, zinc could 
decrease the activity of PgaB, which is associated with the de-N-acetylation of E. coli PGA 
(Little et al. 2012). However, only A. pleuropneumoniae and S. aureus biofilms were 
stained by WGA and were considered positive for PGA. Some species that did not produce 
PGA under our growth conditions were also inhibited by zinc. Those results indicate that 
the antibiofilm effect of zinc might not be dependent on the presence of PGA but other 
components in the biofilm matrix could influence the antibiofilm activity of zinc. eDNA 
play a key role in the composition and formation of biofilms (Whitchurch et al. 2002). For 
most species tested in this study, eDNA was one of the components of their matrix. eDNA 
was reported to function as a zinc chelator and this chelating property can influence the 
stability of biofilms (Mulcahy et al. 2008).  
 
For S. aureus biofilm, we observed that biofilm formation was stimulated by zinc, at 
low concentration. In our test, this phenomenon was not observed for other bacteria. In 
previous studies on S. aureus biofilm, diethylenetriaminepentaacetic acid (DTPA), a metal 
ion chelator, could inhibit biofilm formation, and this inhibitory effect was attributed to the 
chelation of zinc, and not with other metal ions (Conrady, 2008). This might explain the 
positive effect of zinc on S. aureus biofilm formation.  
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In our studies, zinc failed to disperse established biofilms. Our results suggest that 
the antibiofilm activity of zinc is mostly associated with the early steps of biofilm 
formation and not with the dispersion event. One effective method of biofilm control is to 
target community signalling and targeting this type of signalling with antibiofilm molecules 
will prevent biofilm formation (Costerton, 1999).  
 
Zinc may interfere with cellular mechanisms during biofilm development, such as 
signalling and regulation. For examples, Zn (II) has a high affinity for Fur (ferric uptake 
regulator) and excess of Zn (II) might result in the down-regulation of Fur-regulated genes 
(Klemm, 2010). Zinc can interfere with toxin-antitoxin systems, which are involved in 
biofilm formation (Papadopoulos, 2012). The MqsR/MqsA, a toxin-antitoxin system, 
regulates biofilm formation and development of persister cells of E. coli. MqsR, as a toxin, 
contains a well-defined N-terminal domain with a zinc finger motif, which binds zinc. The 
toxin-antitoxin system can be found in many pathogenic bacteria (Gerdes, 2005). c-di-GMP 
plays an important role in the regulation of biofilm formation, and the interference in the c-
di-GMP pathway will have an impact on the biofilm formation. Zn (II) could inhibit the 
EAL domains of cyclic diguanylate phosphodiesterases and this inhibitory effect will block 
the degradation of c-di-GMP (Tamayo, 2005; Jenal and Malone, 2006).  
 
Zinc has already been used in the diet of pigs to treat diseases and to increase feed 
intake. Previous studies using zinc as additive in pigs diet indicate its clinical value. For 
example, ZnO supplement reduced ETEC excretion (Slade, 2011). ZnO as an additive in 
diets benefits weaned pigs by suppressing infection and mediating the development of the 
small intestine mucosa (Slade, 2011). In addition, the inclusion of ZnO (3000 mg/kg) in the 
diet of post-weaning piglets improved their feed intake growth and reduced the incidence of 
diarrhea (Molist, 2011). Zinc supplementation at 500 or 750 mg/kg  with MMT 
(montmorillonite hybrid) was effective to reach pharmacological levels of zinc ( 2000 
mg/kg of zinc) (Hu et al. 2012). 
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In our studies, zinc inhibited biofilm formation of most bacterial species tested. This 
antibiofilm activity of zinc could be beneficial during antibiotics or disinfectants treatment. 
ZnO has been previously combined with an antibacterial agent, which resulted in an 
improvement of performance marker (Hill, 2001). For the 28-d postweaning period, gains 
and feed intakes of pigs increased when carbadox and zinc was added as dietary 
supplement in the feed. The performance responses to ZnO and the antibacterial agent 
carbadox were additive (NB. Health Canada issued an order to stop the sale of carbadox in 
2001). However, it is not known whether this effect would occur with other antibacterial 
agents (Hill, 2001). Therefore, zinc might have a high potential of synergistic effect with 
biocides.  
 
Other metals have been studied for the effect of biofilm formation, such as copper, 
which could prevent the formation of S. aureus biofilms by repressing the positive biofilm 
regulator Agr and Sae. However, the addition of manganese, magnesium, and calcium has 
no significant effect on biofilm formation (Baker et al. 2010). Gallium shows inhibitory 
effect on biofilm infection by disrupting bacterial iron metabolism (Kaneko et al. 2007). 
 
The development of antibiofilm agents as novel therapeutic molecules is given 
promising results; however, the main problems with the development of such molecules are 
largely economic costs (Romero and Kolter, 2011). Zinc is a potential agent for the 
prevention of biofilm-associated infection. Considering zinc is a simple and inexpensive 
molecule with a wide spectrum of antibiofilm effect, it would be worth to further research 
the synergic effects of zinc with antibiotic or disinfectant treatment. In addition, the present 
study only measured the effect of zinc on a single–species biofilm, and the effects of zinc 
on multiple species biofilm should be investigated in future studies. 
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VI. Conclusion 
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Biofilm formation is considered as a major virulence factor in many bacterial 
infections. Microorganisms that form biofilms are of major significance for animal health 
and public health due to the reduced susceptibility of biofilms to antimicrobial agents. An 
effective agent should also take into consideration the impact of drug resistance resulting 
from biofilm formation, and the environmental toxicity. 
 
We have shown that at micromolar concentrations (0 – 250 µM), zinc (ZnCl2 or 
ZnO) weakly inhibited bacterial growth and effectively blocked biofilm-formation of 
several Gram-positive and Gram-negative pathogens of swine. Zinc has a wide spectrum of 
antibiofilm activity that possibly affects the biofilm matrix components and the biofilm 
formation process.The components of biofilm matrix function as the structure and adhesion 
agents. Small molecules that interact with components of the biofilms may break the 
biofilm. In addition, cell-to-cell communication systems play an important role in biofilm 
maturation and development. Small molecules that interfer with cell-to-cell communication 
may prevent biofilm formation and keep the cells in a planktonic state. The antibiofilm 
property of zinc could perhaps enhance the susceptibility of biofilms to antimicrobial 
agents. The inhibitory effect of zinc on biofilm formation may not be limited to specific 
bacteria, but may extend to other important human and animal bacterial pathogens.  
 
Zinc has already been used as an additive in feed of production animals, especially 
pigs. The antibiofilm property of zinc has the potential to have synergic effect with 
antibiotics or disinfectants in the fight against bacterial infections. This should be the focus 
of future studies. 
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